Schulke
Schülke & Mayr GmbH, commonly known as Schülke, is a leading provider of infection prevention and hygiene solutions, headquartered in Norderstedt, Germany. Founded in 1889, the company has established a strong presence in Europe and beyond, focusing on the healthcare, pharmaceutical, and food industries. Schülke is renowned for its innovative products, including antiseptics, disinfectants, and preservation solutions, which are designed to enhance safety and efficacy in various applications. The company’s commitment to quality and sustainability sets it apart in a competitive market, earning it a reputation for excellence. With a rich history of milestones, Schülke continues to be a trusted partner in infection control, contributing significantly to public health and safety initiatives worldwide.
DitchCarbon Score
How does Schulke's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Schulke's score of 5 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Schulke's reported carbon emissions
In 2023, Schülke & Mayr GmbH reported absolute Scope 1 emissions of approximately 2,973,540 kg CO2e. This figure reflects a significant reduction from previous years, with emissions of about 3,524,510 kg CO2e in 2022 and 3,415,590 kg CO2e in 2021. The company has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2021 as the baseline year. Additionally, Schülke & Mayr has committed to a 25% reduction in absolute Scope 3 emissions from purchased goods and services within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to global efforts to limit warming to 1.5°C. Schülke & Mayr's proactive approach underscores its commitment to sustainability within the pharmaceuticals and biotechnology sector, based in Germany.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2011 | 2012 | 2013 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 5,444,217 | 0,000,000 | 0,000,000 | 000,000.0 | 0,000,000.0 | 0,000,000.0 | 000,000.0 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 5,455,182 | 0,000,000 | 0,000,000 | - | - | - | - | - | - | - | - |
| Scope 3 | 191 | 000 | 000 | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Schulke is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
